YALGREFI

Serial Number 79417168
Registration 7979947
700

Registration Progress

Application Filed
Jan 16, 2025
Under Examination
Approved for Publication
Aug 20, 2025
Published for Opposition
Aug 26, 2025
Registered
Oct 14, 2025

Trademark Image

YALGREFI

Basic Information

Serial Number
79417168
Registration Number
7979947
Filing Date
January 16, 2025
Registration Date
October 14, 2025
Published for Opposition
August 26, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 14, 2025
Registration
Registered
Classes
005

Rights Holder

TAIHO PHARMACEUTICAL CO., LTD.

03
Address
1-27 Kandanishiki-cho,
Chiyoda-ku Tokyo 101-8444
JP

Ownership History

TAIHO PHARMACEUTICAL CO., LTD.

Original Applicant
03
JP

TAIHO PHARMACEUTICAL CO., LTD.

Owner at Publication
03
JP

TAIHO PHARMACEUTICAL CO., LTD.

Original Registrant
03
JP

USPTO Deadlines

Next Deadline
2100 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20251014)
Due Date
October 14, 2031
Grace Period Ends
April 14, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description Documents
Nov 13, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Oct 14, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 26, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 20, 2025 NPUB O NOTICE OF PUBLICATION Loading...
Jul 18, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 25, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 4, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 4, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 4, 2025 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Feb 13, 2025 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Anti-cancer preparations; pharmaceutical preparations for the treatment of tumor; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of immune disorders; pharmaceutical preparations for the treatment of hematological disorders

Classification

International Classes
005